GlassScriptPhysician profile
Ludane Simmons
NPI 1114367364
$1,023.15
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.08 · 2020: $105 · 2021: $378 · 2022: $277 · 2023: $86.02 · 2024: $96.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $182.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $270.69 | 2019-2023 | Evenity, Prolia |
| Boston Scientific Corporation | $142.68 | 2022-2023 | Wavewriter Alpha Prime 16 |
| Lilly USA, LLC | $129.36 | 2020-2022 | |
| Abbvie INC. | $99.26 | 2021-2022 | |
| Novo Nordisk INC | $96.76 | 2019-2023 | Wegovy |
| Abbott Laboratories | $96.65 | 2024 | Amplatzer Talisman |
| Nevro Corp. | $63.22 | 2021 | |
| Tactile Systems Technology INC | $27.58 | 2022-2023 | Flexitouch Plus, Entre Plus |
| Biohaven Pharmaceuticals, INC. | $19.35 | 2021 | |
| Astellas Pharma US INC | $17.97 | 2022 | |
| Sanofi-Aventis U.S. LLC | $16.52 | 2021 | |
| Glaxosmithkline, LLC. | $15.85 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $14.37 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ludane Simmons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.